Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional cell bladder tumours.
Rosen
M
M
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy; D015251:Epirubicin / Q000009:adverse effects*; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000150:complications*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D001743:Urinary Bladder / Q000187:drug effects / Q000293:injuries*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin